Infectious disease and pharmacology: neonatology questions and controversies

Part 1: Infectious disease. Management of the asymptomatic newborn at risk for sepsis -- Empirical therapy for neonatal sepsis -- When and how to treat neonatal CMV infections -- Neonatal herpes simplex virus infection -- Antibiotic stewardship -- Candida prophylaxis -- Diagnosis, risk factors, outcomes, and evaluation of invasive candida infections -- When to perform lumbar puncture in infants at risk for meningitis in the neonatal intensive care unit -- Biomarkers in diagnosis of neonatal sepsis -- Congenital Zika syndrome -- Part 2: Pharmacology. Pharmacokinetic considerations in neonates -- Neonatal pharmacogenetics -- Antibiotic considerations for necrotizing enterocolitis -- Antibiotic dosing considerations for term and preterm infants -- Antifungal dosing considerations for term and preterm infants -- Antiviral dosing considerations for term and preterm infants -- Antiepileptic drug therapy in neonates -- Neuroprotective therapies in neonates -- Pharmacologic therapy for neonatal abstinence syndrome -- Therapies for gastroesophageal reflux in neonates"